In a report released today, Andrew Semple from Echelon Wealth Partners maintained a Buy rating on Indiva (NDVAF – Research Report). The company’s shares closed last Wednesday at $0.20, close to its 52-week low of $0.16.
According to TipRanks.com, Semple is a 4-star analyst with an average return of 28.8% and a 31.4% success rate. Semple covers the Basic Materials sector, focusing on stocks such as Green Thumb Industries, Fire & Flower Holdings, and Trulieve Cannabis.
Indiva has an analyst consensus of Moderate Buy.
Based on Indiva’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $7.72 million and GAAP net loss of $6.43 million. In comparison, last year the company earned revenue of $3.03 million and had a GAAP net loss of $3.57 million.
Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of NDVAF in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Indiva Ltd. engages in the construction of a medical marijuana facility. It offers dried cannabis flower, chocolate, accessories, and oil. The company was founded by Niel Marotta and Koby Smutylo on May 12, 2015 and is headquartered in Ottawa, Canada.
Read More on NDVAF: